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Case Report
Primary fallopian tube carcinoma 
presenting with a solitary metastasis 
in a Spigelian hernia
Abstract
Primary fallopian tube carcinoma (PFTC) is a rare 
gynaecological tumour.
Histologically, this type of tumour resembles other tumours 
of the female reproductive tract, predominantly serous tumours. 
These cancers are often difficult to distinguish from ovarian 
cancers and are generally treated with the same standards of 
surgery and chemotherapy. Diagnosis of PFTC is rarely made 
preoperatively. Very often, the diagnosis is made either at the 
operating table or by the pathologist. In this report we present 
a rare case of PFTC with a solitary metastatic deposit in a 
right Spigelian hernia, the latter being the initial presenting 
complaint.  
Case report
A 65 year old nulliparous female presented at the surgical 
out-patient department with a two month history of a lump 
on the right side of her abdomen. The patient complained of 
some degree of abdominal discomfort especially when the 
lump became more prominent. Clinical examination revealed 
a partially reducible lump with a palpable cough impulse 
along the right linea semilunaris just below the level of the 
umbilicus. A diagnosis of Spigelian hernia was put forth. In 
order to confirm the diagnosis, a CT scan of the abdomen 
(Figure 1) was performed and this confirmed the presence of 
the Spigelian hernia. Following this a standard repair of the 
hernia was scheduled.
At operation the hernia was approached via a transverse skin 
incision over the lump. The anterior rectus sheath and external 
oblique aponeurosis were incised to expose the sac. Once the 
sac was opened, an encysted gelatinous mass was exposed. The 
cystic mass had a long pedicle extending down into the pelvis. 
The pedicle was ligated and excised. The cyst was sent in toto 
for histology.
The pathology report stated that the cystic mass measured 
4.5x3.0x2.5cm. On sectioning, it was cystic, multilobulated, 
and contained yellowish, mucinous fluid. The cyst was smooth 
and contained a 0.7cm nodule. Microscopically (Figure 2), it 
was reported as a poorly differentiated adenocarcinoma in a 
peritoneal hernial sac. This could represent a primary peritoneal 
tumour or metastasis from other sites such as the ovary, however 
other possible primary sites had to be excluded. Therefore a CT 
scan of the abdomen and pelvis (Figure 3) was performed. This 
showed a slightly enlarged and irregular right adnexa. A serum 
CA-125 radioimmunoassay was performed and this was grossly 
elevated at 156.00 U/ml (1.9-16.3 U/ml). The case was discussed 
and a joint laparatomy with a gynaecologist was performed.
At operation the CT findings of an enlarged and irregular 
right adnexa was confirmed. Both ovaries, the left fallopian 
tube, omentum and pelvic and para-aortic lymph nodes looked 
normal and there was no evidence of intraperitonral spread. 
Consequently, the gynaecologist proceeded to perform a total 
abdominal hysterectomy, bilateral salpingo-oophorectomy and 
omentectomy followed by a thorough peritoneal lavage. 
The histology was that of an invasive poorly differentiated 
serous adenocarcinoma of the right fallopian tube which was 
ruptured and adhesions were extending between the tube and 
the attached right ovary. The latter was otherwise normal. The 
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findings were consistent with a primary fallopian tube carcinoma 
(Figure 4). The omentum was free of any metastatic deposit. 
The uterus and left adnexa were normal.
The patient made an uneventful recovery and was referred 
to the oncologist. She underwent 4 cycles of paclitaxel and 
carboplatin. Before her first cycle the CA-125 level was 8 U/ml. 
After the fourth cycle the CA-125 was 7.6 U/ml. One and three 
years later the CA-125 was still within the normal range. Her liver 
function tests and other tumour markers were and remained 
within normal range too.
Discussion
Primary fallopian tube carcinoma (PFTC) is a rare form of 
gynaecological tumour, with an incidence varying from 0.3% 
to 1.1% of all gynaecological cancers.4,13  Tubal carcinoma has 
been reported in females from 14 to 87 years of age, with a 
peak incidence in the early 60’s.4,5  In fact our patient was in 
her mid-sixties. PFTC is more common in nulliparous females 
as was our case. This was established from a meta-analysis of 
cases reported between 1973 and 1992. This showed a nulliparity 
rate of 27.5% and a mean parity of 1.7%.5   Historically, Renauld 
reported the first case in 1847.6 Up to 1998 a total of 1500 cases 
Figure 1: CT scan of the abdomen depicting the right 
Spigelian hernia
Figure 3: CT scan of the pelvis showing the enlarged and 
irregular right adnexa
Figure 2: Histological view of the nodule in the peritoneal 
hernial sac - poorly differentiated adenocarcinoma 
Figure 4: Poorly differentiated serous adenocarcinoma of 
the right fallopian tube
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of tubal carcinoma have been reported either in small series 
or individual case reports.7,10  Major risk factors for fallopian 
tube carcinoma appears to be similar to those for ovarian 
carcinoma, oral contraceptives and childbearing both being 
strongly protective.15 
The problem with these primary fallopian tube tumours is 
their difficulty in being diagnosed. The trio of abdominal pain, 
watery vaginal discharge, and metrorrhagia is considered by 
many as pathognomonic.6  Unfortunately, however, only a 
minority of cases present in this way. In fact, one of the papers 
reviewed, reported that 43% of patients were asymptomatic.5 
In this specific paper by Nordan (1994), which dealt with a 
retrospective analysis of seven patients with PTFC, not one of 
these patients had a correct pre-operative diagnosis. Similarly, 
Butler et al, (1999) reported that in their series of 26 patients, 
no patient was correctly diagnosed pre-operatively.14 Figliolini 
et al., in 1997 reported that over the previous 40 years the pre-
operative diagnosis had actually increased from 0.26% - 6.38%.5 
In the symptomatic group of patients preoperative diagnosis 
can be achieved   by a combination of an abnormal cervical, 
elevated CA-125, ultrasonography or CT scan of the pelvis and 
laparascopy. A study by Kujak  et al. published in 2005 showed 
that a three dimensional ultrasound allows a precise depiction 
of tubal wall irregularities. Study of the vascular architecture in 
cases of fallopian tube malignancies could be further enhanced 
by 3D power Doppler imaging.16  The tumour marker Serum 
Cancer Antigen 125 (CA 125) is often elevated as was the case in 
our patient. In a reported series of patients with elevated CA-125, 
the ratio of epithelial ovarian to tubal cancer was 6:1.11 A high 
serum CA-125 does not therefore distinguish primary ovarian 
from primary fallopian tube carcinoma. Besides, it is important 
to emphasis that CA-125 assays can be elevated in the absence 
of carcinoma and in the presence of other non related cancers. 
Therefore reliable pre-operative diagnosis requires a high index 
of suspicion and careful exclusion of alternative pathologies 
by radiological means. However, as in ovarian cancers, serum 
CA-125 are important markers of prognosis and therapeutic 
response to treatment independent of tumour stage. The pre-
treatment CA-125 levels correlate well with the tumour stage but 
not with lymph node involvement, patient age or histological 
grade. This study also showed that in 90% of patients, a rise 
in the level of CA-125 preceded the clinical or radiological 
recurrence of disease by an average of three months.12 
Several studies have cited that fallopian tube cancers have 
similar somatic genomic alterations compared with serous 
ovarian cancers and hence PFTC may arise in association with 
germ-line mutations of BRCA1 and BRCA2.17  The cumulative 
lifetime risk of developing heriditary breast ovarian cancer 
syndrome approaches 100%.18 These hereditary breast 
ovarian syndromes include fallopian and primary peritoneal 
cancers.19,20 
Mangement of PFTC  depends on the stage of the disease, 
this being based on the FIGO system. Stage I and II patients 
are known to do very well with primary surgical and adjuvant 
therapy, while the prognosis of Stage III/IV patients is much 
worse. Significant levels of long term survival can be achieved 
with aggressive treatment in the latter group.14 The surgical 
management includes 1) total abdominal hysterectomy 
and bilateral salpingo-oophorectomy, 2) omentectomy and 
peritoneal lavage and 3) selective para-aortic and pelvic 
lymhadenectomy. Adjuvant chemotherapy administration 
depends on the stage of the disease. The case we present was 
stage III and she underwent total abdominal hysterectomy and 
bilateral salpingooophorectomy and omentectomy followed by 
adjuvant chemotherapy. Lymphadenectomy was not performed 
as there were no enlarged lymph nodes at laparatomy.
An extensive literature search regarding metastatic 
presentation of PFTC has revealed that apart from splenic 
metastases8 and inguinal lymph node metastases9 there has 
been no report of an isolated metastatic deposit from a PFTC 
in a Spigelian hernia.
The incidence of Spigelian hernia is not generally known 
but in one series of 1800 anterior abdominal wall herniae, an 
incidence of 0.5% was reported.1 It is slightly more common 
in females and the median age is 50 years. The hernia is often 
impalpable, especially if the patient is obese and the only 
symptoms may be of vague abdominal pain. If a mass is present 
it may have a cough impulse and it may be reducible. However, 
20% present with strangulation and intestinal obstruction.2   It 
is not uncommon for its contents to be irreducible. Ultrasound 
and CT Scanning can easily confirm a Spigelian hernia and 
differentiate it from other abdominal wall masses such as 
abscesses, tumours, lipomas or haematomas.3 An online 
literature search revealed a report of a primary serous papillary 
carcinoma in a Spigelian hernia.21 
Conclusion
This case report highlights the fact that an ordinary 
presentation such as a partially reducible hernia, as was the 
case, may belie a more sinister pathology. This illustrates 
the importance of submitting all specimens for histological 
analysis.
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